Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

VolitionRX Limited Common Stock (NY: VNRX )

0.4870 -0.0030 (-0.61%)
Official Closing Price Updated: 8:00 PM EDT, Apr 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 125,910
Open 0.4700
Bid (Size) 0.4603 (13)
Ask (Size) 0.5500 (11)
Prev. Close 0.4900
Today's Range 0.4676 - 0.4900
52wk Range 0.4200 - 1.020
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Get insights into the top gainers and losers of Friday's after-hours session.
The regular session of the US market on Friday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements. 
Via Chartmill
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga

Performance

YTD
-22.70%
-22.70%
1 Month
-5.42%
-5.42%
3 Month
-22.07%
-22.07%
6 Month
-29.97%
-29.97%
1 Year
-45.29%
-45.29%

More News

Read More
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
A Look Ahead: VolitionRX's Earnings Forecast
Via Benzinga
Earnings Preview For VolitionRX
Via Benzinga
This Weyerhaeuser Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Via Benzinga
Earnings Scheduled For March 31, 2025
Via Benzinga
Earnings Outlook For VolitionRX
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Life Sciences Virtual Investor Forum Agenda Announced for September 19th
From Virtual Investor Conferences
Via GlobeNewswire
VNRX Stock Earnings: VolitionRX Beats EPS, Misses Revenue for Q2 2024
Via InvestorPlace
Earnings Scheduled For November 14, 2024
Via Benzinga
BioMedNewsBreaks — VolitionRx Limited (NYSE American: VNRX) appoints PharmaVentures for Capture PCR(TM) and Oncology Portfolio Licensing
Via Investor Brand Network
BioMedNewsBreaks — VolitionRx Limited (NYSE American: VNRX) Highlights Latest Achievements in Mid-Year Review
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
Nexalin Technology and VolitionRX Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Via ACCESSWIRE
VNRX Stock Earnings: VolitionRX Beats EPS, Misses Revenue for Q1 2024
Via InvestorPlace
VolitionRx Ltd. (NYSE American: VNRX) Featured in Coverage of the EF Hutton Annual Global Conference
Via Investor Brand Network
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
VNRX Stock Earnings: VolitionRX Meets EPS, Misses Revenue for Q4 2023
Via InvestorPlace
Earnings Scheduled For March 25, 2024
Via Benzinga
Next Big Thing: 3  Biotech Stocks to Watch for Groundbreaking Advances
Via InvestorPlace
Topics Economy
Exposures Economy
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why Trinity Place Holdings Shares Are Trading Higher By 80%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.